The Use of the Esclera Scleral Contact Lens in the Treatment of Moderate to Severe Dry Eye Disease

Weber, S.; Souza, Rodrigo Becco de; Gomes, José Álvaro Pereira; Hofling-Lima, Ana Luísa

doi:10.1016/j.ajo.2015.11.034

Cited by 52 publications

(24 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This effect may be associated with the impairment of the NEI and TBUT scores on the first postoperative day. La Porta Weber et al [20] reported that contact lens acts as a protective covering for the cornea by controlling evaporation and maintaining direct contact between the fluid and the corneal epithelium. The contact lens also protects the cornea from abrasions and mechanical trauma, which commonly result from eyelid scar irregularities.…”

Section: Discussionmentioning

confidence: 99%

Efficacy of Bandage Contact Lenses versus Eye Patching in Early Postoperative Period of Müller’s Muscle-Conjunctival Resection

2020

View full text Add to dashboard Cite

Purpose: Patients with blepharoptosis who are treated with Müller’s muscle-conjunctival resection (MMCR) may experience postoperative pain and discomfort related to the suture material on the palpebral conjunctiva. This study aims to compare the postoperative subjective complaints, such as pain and discomfort, with a visual analog scale (VAS), and objectively evaluate the cornea with a tear break-up time (TBUT) test and fluorescein staining following MMCR that was managed by either a bandage contact lens (BCL) or eye patching. Methods: Forty patients who had undergone a unilateral MMCR were randomized into 2 groups. Group 1 (n = 20) received a BCL, and group 2 (n = 20) received an eye patch following the MMCR. Patients were evaluated postoperatively at 1 and 7 days in this prospective study. The postoperative pain was measured using a VAS, and the requirement for anti-inflammatory medication was analyzed. A slit-lamp examination was performed to evaluate the cornea with a TBUT test and fluorescein staining by objectively using the National Eye Institute (NEI) classification. Results: BCL treatment decreased the VAS score, the need for anti-inflammatory medications, and fluorescein staining using the NEI score and increased the TBUT score significantly compared with the eye patch treatment (p < 0.001). Conclusions: Our findings suggest that the use of a BCL may be beneficial in terms of reducing early postoperative pain and eye stinging, protecting the cornea, and retaining the ability to perform daily activities following a MMCR.

show abstract

Section: Discussionmentioning

confidence: 99%

Efficacy of Bandage Contact Lenses versus Eye Patching in Early Postoperative Period of Müller’s Muscle-Conjunctival Resection

2020

View full text Add to dashboard Cite

show abstract

“…The one patient with Sjøgren syndrome in the cohort did not end up wearing the lenses for unspecified reasons [261]. A prospective interventional case series of 41 eyes fitted with a scleral lens (Esclera), 11 of which had dry eye associated with Sjøgren, reported both improvement in symptoms and quality of life, based on OSDI and Short-Form Health Survey (SF-36v2) scores, respectively; however, data for Sjogren's patients was not analysed separately [238].…”

Section: Sjøgren Syndromementioning

confidence: 99%

BCLA CLEAR – Medical use of contact lenses

Jacobs

Carrasquillo²,

Cottrell

et al. 2021

Contact Lens and Anterior Eye

View full text Add to dashboard Cite

The medical use of contact lenses is a solution for many complex ocular conditions, including high refractive error, irregular astigmatism, primary and secondary corneal ectasia, disfiguring disease, and ocular surface disease. The development of highly oxygen permeable soft and rigid materials has extended the suitability of contact lenses for such applications. There is consistent evidence that bandage soft contact lenses, particularly silicone hydrogel lenses, improve epithelial healing and reduce pain in persistent epithelial defects, after trauma or surgery, and in corneal dystrophies. Drug delivery applications of contact lens hold promise for improving topical therapy. Modern scleral lens practice has achieved great success for both visual rehabilitation and therapeutic applications, including those requiring retention of a tear reservoir or protection from an adverse environment. This report offers a practical and relevant summary of the current evidence for the medical use of contact lenses for all eye care professionals including optometrists, ophthalmologists, opticians, and orthoptists. Topics covered include indications for use in both acute and chronic conditions, lens selection, patient selection, wear and care regimens, and recommended aftercare schedules. Prevention, presentation, and management of complications of medical use are reviewed.

show abstract

“…Tarsorrhaphy and cicatricial release can be used to treat lagophthalmos as well. In the setting of posterior eyelid margin keratinization or scarring resulting in entropion, mucous membrane grafting (MMG) or scleral lenses such as the PROSE lens are most appropriate ( 5 , 63 , 64 ).…”

Section: Treatment Strategy For Sjs/ten With Soc In the Chronic Stagementioning

confidence: 99%

“…PROSE is a treatment that utilizes a gas-permeable, large-diameter contact lens which provides a protective barrier over the cornea and submerges the entire corneal surface in a pool of oxygenated artificial tears creating an environment which supports healing and maintenance of the corneal epithelium ( 63 , 74 ). It also improves visual acuity and comfort and reduces corneal complications ( 41 , 64 , 75 ). Symblephara may need management before a lens can be fitted properly ( 21 ).…”

Section: Treatment Strategy For Sjs/ten With Soc In the Chronic Stagementioning

confidence: 99%

Acute and Chronic Management of Ocular Disease in Stevens Johnson Syndrome/Toxic Epidermal Necrolysis in the USA

et al. 2021

View full text Add to dashboard Cite

Stevens Johnson syndrome and toxic epidermal necrolysis are on a spectrum of a severe, immune-mediated, mucocutaneous disease. Ocular involvement occurs in the vast majority of cases and severe involvement can lead to corneal blindness. Treatment in the acute phase is imperative in mitigating the severity of chronic disease. Advances in acute treatment such as amniotic membrane transplantation have shown to significantly reduce the severity of chronic disease. However, AMT is not a panacea and severe chronic ocular disease can and does still occur even with aggressive acute treatment. Management of chronic disease is equally critical as timely intervention can prevent worsening of disease and preserve vision. This mini-review describes the acute and chronic findings in SJS/TEN and discusses medical and surgical management strategies.

show abstract

The Use of the Esclera Scleral Contact Lens in the Treatment of Moderate to Severe Dry Eye Disease

Abstract: The Esclera SCL treatment had a positive impact on tear osmolarity and van Bijsterveld score, as well as an improvement in the patients' BCVA, dry eye symptoms, and quality of life.

Cited by 52 publications

References 31 publications

Efficacy of Bandage Contact Lenses versus Eye Patching in Early Postoperative Period of Müller’s Muscle-Conjunctival Resection

Efficacy of Bandage Contact Lenses versus Eye Patching in Early Postoperative Period of Müller’s Muscle-Conjunctival Resection

BCLA CLEAR – Medical use of contact lenses

Acute and Chronic Management of Ocular Disease in Stevens Johnson Syndrome/Toxic Epidermal Necrolysis in the USA

Contact Info

Product

Resources

About